Thomas Müller

Title: Thomas Müller: Innovator in Breathing Disorder Treatments

Introduction

Thomas Müller is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of breathing disorders. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Müller's most recent patent is titled "Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders." This invention relates to novel diazabicyclically substituted imidazo[1,2-a]pyrimidine derivatives. The patent outlines methods for producing these compounds and their applications in treating and preventing diseases, especially those related to breathing disorders, including obstructive and central sleep apnea, as well as snoring.

Career Highlights

Throughout his career, Thomas Müller has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft, where he has contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing treatments for respiratory conditions.

Collaborations

Müller has collaborated with several professionals in his field, including Martina Delbeck and Michael Hahn. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.

Conclusion

Thomas Müller is a distinguished inventor whose work has significantly impacted the treatment of breathing disorders. His patent on diazabicyclic substituted imidazopyrimidines showcases his commitment to improving health outcomes. Through his career and collaborations, he continues to contribute to advancements in medical science.